FDA approves pralsetinib for non-small cell lung cancer with RET gene fusions

FDA approves pralsetinib for non-small cell lung cancer with RET gene fusions

http://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-pralsetinib-n...

Source: FDA Center for Drug Evaluation and Research - What's New - August 9, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Genetics | Lung Cancer | Non-Small Cell Lung Cancer